If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Director/PDMR Shareholding

26 Jan 2017 10:10

RNS Number : 2106V
Scapa Group PLC
26 January 2017
 

26 January 2017

SCAPA GROUP PLC

('the Company')

Director/PDMR Notification

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Scapa Group plc (AIM: SCPA), a global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets, was notified on 25 January 2017 that James Archibald Simpson Wallace, Group Chairman of the Company, sold 150,000 ordinary shares of 5 pence each in the share capital of the Company ('Ordinary Shares') at a price of 320 pence per Ordinary Share and 250,000 ordinary shares of 5 pence each in the share capital of the Company ('Ordinary Shares') at a price of 321 pence per Ordinary Share on 25 January 2017, as detailed below.

On 15 December 2016, Mr Wallace announced his retirement as Chairman of the Board of Scapa Group plc with effect from 31 March 2017, at which point Mr Larry Pentz will assume Chairmanship.

Following the sale Mr. Wallace holds 70,000 Shares in the Company.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Archibald Simpson Wallace

 

2

Reason for the notification

a)

Position / status

Group Chairman

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of financial instrument,

type of instrument

 

Ordinary shares of 5p each

Identification Code

GB0007281198

b)

Nature of the transaction

Sale of shares

 

c)

Price(s) and volume(s)

 

Sale of 150,000 shares at 320p per share

Sale of 250,000 shares at 321p per share

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

25 January 2017

f)

Place of the transaction

London

 

For further information please contact:-

 

Graham Hardcastle Group Finance Director/Company Secretary

Scapa Group plc

Tel: 0161 301 7400

 

Richard Thomas Numis Securities Limited

Nominated Adviser and Joint Broker

Tel: 0207 260 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUNRRRBKAAUAR
Date   Source Headline
12th Jun 20191:16 pmRNSDirector/PDMR Shareholding
12th Jun 20199:16 amRNSHolding(s) in Company
11th Jun 201910:28 amRNSHolding(s) in Company
10th Jun 20192:50 pmRNSAnnual Report and Notice of AGM
10th Jun 201910:05 amRNSHolding(s) in Company
10th Jun 20197:00 amRNSBoard update and additional information
3rd Jun 20194:32 pmRNSHolding(s) in Company
3rd Jun 20197:00 amRNSNotice of Termination of Material Contract
31st May 20199:19 amRNSTotal Voting Rights
28th May 201910:57 amRNSHolding(s) in Company
22nd May 20192:11 pmRNSHolding(s) in Company
21st May 20197:00 amRNSHeejae Chae to step down as Group CEO of Scapa
21st May 20197:00 amRNSScapa Group: Preliminary Results
30th Apr 20199:33 amRNSTotal Voting Rights
26th Apr 20192:21 pmRNSHolding(s) in Company
25th Apr 20192:15 pmRNSHolding(s) in Company
11th Apr 20197:00 amRNSYear-end trading update
29th Mar 20198:50 amRNSTotal Voting Rights
6th Mar 20194:12 pmRNSDirector/PDMR Shareholding
6th Mar 20199:43 amRNSPDMR Notification
28th Feb 20193:23 pmRNSTotal Voting Rights
12th Feb 20194:53 pmRNSDirector/PDMR Shareholding
8th Feb 20194:38 pmRNSDirector/PDMR Shareholding
25th Jan 20198:00 amRNSBlock listing Interim Review
23rd Jan 20197:00 amRNSCapital Markets Day
22nd Jan 20197:00 amRNSDirectorate Change
31st Dec 20189:08 amRNSTotal Voting Rights
21st Dec 201810:16 amRNSDirector/PDMR Shareholding
13th Dec 20184:40 pmRNSDirectorate Change
11th Dec 20182:52 pmRNSDirector/PDMR Shareholding
30th Nov 20189:35 amRNSTotal Voting Rights
23rd Nov 20184:05 pmRNSDirector/PDMR Shareholding
21st Nov 201810:46 amRNSDirector/PDMR Shareholding
20th Nov 20187:00 amRNSHalf-year Report
8th Nov 20184:08 pmRNSHolding(s) in Company
31st Oct 20189:57 amRNSTotal Voting Rights
10th Oct 20187:00 amRNSTrading Statement
2nd Oct 20187:00 amRNSAcquisition
28th Sep 201810:42 amRNSTotal Voting Rights
21st Sep 201812:27 pmRNSDirector/PDMR Shareholding
17th Sep 201810:07 amRNSAnnual Financial Report
13th Sep 20188:21 amRNSAcquisition
31st Aug 20189:53 amRNSTotal Voting Rights
24th Aug 20187:00 amRNSDirectorate Change
7th Aug 201811:59 amRNSBlock listing Interim Review
31st Jul 201810:11 amRNSTotal Voting Rights
26th Jul 20183:26 pmRNSBlock listing Interim Review
17th Jul 20182:46 pmRNSResult of AGM
17th Jul 20187:00 amRNSAGM Statement
10th Jul 20184:08 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.